Trial Profile
Efficacy of AlbenDazole to inDuce mUcosal healing in Patients with Crohn's disease on anti-TNF monotherapy
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs Albendazole (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms ADD UP
- 03 Jul 2020 Status changed from recruiting to discontinued.
- 07 Aug 2018 New trial record